iXpressGenes
Huntsville, US · Alabama corporation
Biotech
Founders & leadership
JS
John SchmittExecutive Officer, Director
JN
Joseph NgExecutive Officer, Director
PS
Peggy SammonDirector
BF
Barbara FiskDirector
Reported raises · per SEC filings
Form D private placements▶$2.4MraisedJun 2025 · 13 investors · BiotechnologyRule 506(b)
▶$2.4MraisedJun 2025 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peggy SammonDirector
- John SchmittExecutive Officer, Director
- Barbara FiskDirector
- Joseph NgExecutive Officer, Director
- Offering amount
- $4.2M
- Amount sold
- $2.4M
- First sale
- Sep 2009
- Incorporated
- Corporation, Alabama
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 9 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Department of DefenseOffice for Chemical and Biological Defense | Phase II | 2017 | $1000K |
| National Institutes of Health (NIH)National Institutes of Health | Phase IISTTR | 2016 | $958.3K |
| Department of DefenseOffice for Chemical and Biological Defense | Phase I | 2016 | $143.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2015 | $150K |
| National Institutes of Health (NIH)National Institutes of Health | Phase IISTTR | 2013 | $743.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2010 | $744.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2010 | $100K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2008 | $100K |
| National Science Foundation | Phase ISTTR | 2006 | $100K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.